-
![Ubrogepant]()
UbrogepantCAS Registry Number: 953762-84-8. Molecular Formula: C29H26F6N6O3. Molecular Weight: 624.55 g/molread more -
![Anastrozole]()
AnastrozoleAnastrozole lowers estrogen levels in postmenopausal women, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.read more -
![Ensitrelvir Fumaric Acid]()
Ensitrelvir Fumaric AcidCAS No. 2757470-18-9. Molecular Formula: C26H21ClF3N9O6. Molecular Weight: 647.95 g/molread more -
![Fezolinetant]()
FezolinetantCAS Number: 1629229-37-3. Molecular Formula: C16H15FN6OS. Molecular Weight: 358.39 g/molread more -
![Abrocitinib]()
AbrocitinibCAS Registry Number: 1622908-18-2. Molecular Formula: C14H21N5O. Molecular Weight: 275.35 g/molread more -
![Baricitinib]()
BaricitinibCAS No. 1187594-09-7. Molecular Formula: C16H17N7O2S. Molecular Weight: 371.42 g/molread more -
![Linagliptin]()
LinagliptinCAS No. 668270-12-0. Molecular Formula: C25H28N8O2. Molecular Weight: 472.54 g/molread more -
![Sorafenib Tosylate]()
Sorafenib TosylateCAS No. 284461-73-0 (Tosylate). Molecular Formula: C21H16Cl2N4O3 · C7H8O3S. Molecular Weight: 637.49 g/mol (Tosylate salt)read more -
![Meloxicam]()
-
![Moxifloxacin Hydrochloride]()
Moxifloxacin HydrochlorideCAS No. 186826-86-8. Molecular Formula: C21H24FN3O4 · HCl. Molecular Weight: 437.90 g/molread more -
![Atorvastatin Calcium]()
Atorvastatin CalciumAPI:Atorvastatin Calcium CAS NO:134523-03-8 Therapeutic Category:Cadiovascular drug Specification:USP latest DMF:TPA* Availability:By orderread more -
![Marbofloxacin]()
MarbofloxacinMarbofloxacin is a carboxylic acid derivative third generation fluoroquinolone antibiotic. It is used in veterinary medicine under the trade names Marbocyl, Forcyl, Marbo vet and Zeniquin. Aread more
David Baker
Franklin Williams
Mike Alvarez
Juliet Young
Ramona Williams
Reda Stroup
May 26, 2022 · Ticagrelor is an antiplatelet medication that’s FDA-approved for a few different things, including: To help lower the risk of dying, having a future heart attack, or having a stroke...
Ticagrelor (Brilique™, Brilinta®), a cyclopentyl-triazolopyrimidine, is an orally active, reversible, and selective adenosine diphosphate (ADP) receptor antagonist indicated for use in patients...
Feb 10, 2020 · Based on the American Heart Association/American College of Cardiology (AHA/ACC) guidelines for the management of patients with non-ST-elevation acute coronary syndromes (NSTE-ACS),...
Jan 22, 2021 · What is ticagrelor? Ticagrelor is used to lower your risk of heart attack, stroke, or death due to a blocked artery or a prior heart attack. Ticagrelor is also used to lower your risk...
Jun 30, 2022 · Ticagrelor can cause significant, sometimes fatal, bleeding. Do not use in patients with active pathological bleeding or history of intracranial hemorrhage. Do not start in patients...
Nov 04, 2022 · Friday, November 4, 2022. If you have any questions, contact a member of your healthcare team directly. If you're a patient at MSK and you need to reach a provider after 5:00 p.m.,...